1992
DOI: 10.1254/jjp.58.231
|View full text |Cite
|
Sign up to set email alerts
|

Antagonism of Platelet-Activating Factor-Induced Increase in Cytosolic Free Calcium Concentration in Human Endothelial Cells.

Abstract: ABSTRACT-The effects of platelet-activating factor (PAF) antagonists on the agonist-induced increase in cytosolic free calcium concentration, [Ca 2+]i, in human vascular endothelial cells grown in monolayer were investigated by a continuous su perfusion technique using a calcium fluorescent probe, fura-2. PAF caused a small but dose-dependent increase in [Ca 2+];. Seven structurally dissimilar PAF antagonists dose-dependently suppressed the peak response, among which WEB 2086 was the most potent, followed by W… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1993
1993
2016
2016

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 27 publications
0
2
0
Order By: Relevance
“…This result indicates that the sonicates contain PAF which was not inactivated by acetylhydrolase (Lee et al, 1982), and that platelet adhesion to thrombogenic endothelial cells requires, at a minimum, the activation of both, or either, the platelets and/or endothelial cells by PAF. Since PAF is a potent agonist in rabbit platelets and a weak agonist in human endothelial cells (Hirafuji & Shinoda, 1992), platelets may be the target cells of PAF. However, PAF alone at a concentration (10nM) that induces full aggregation did not induce platelet adhesion even to the thrombogenic endothelial cells without the sonicates, suggesting that some factor(s) in the sonicates are prerequisite to the ultimate platelet-endothelial cell interactions.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This result indicates that the sonicates contain PAF which was not inactivated by acetylhydrolase (Lee et al, 1982), and that platelet adhesion to thrombogenic endothelial cells requires, at a minimum, the activation of both, or either, the platelets and/or endothelial cells by PAF. Since PAF is a potent agonist in rabbit platelets and a weak agonist in human endothelial cells (Hirafuji & Shinoda, 1992), platelets may be the target cells of PAF. However, PAF alone at a concentration (10nM) that induces full aggregation did not induce platelet adhesion even to the thrombogenic endothelial cells without the sonicates, suggesting that some factor(s) in the sonicates are prerequisite to the ultimate platelet-endothelial cell interactions.…”
Section: Discussionmentioning
confidence: 99%
“…(6-keto-PGFI.) by a specific radioimmunoassay (Hirafuji & Shinoda, 1992 -cyclopentyl-16, 17, 18, 19, 20-pentanor-prostaglandin I2ua-cyclodextrin clathrate), 6-keto-PGFI,. and its antiserum were also kindly provided by Ono Pharmaceuticals Indust., Ltd., Japan.…”
Section: Determination Ofprostacyclinmentioning
confidence: 99%